Regenerative Medical Technology Group Inc. (RMTG) › Cost of RevenueRegenerative Medical Technology Group Inc. (RMTG) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $4.8K2018: $68.3K2019: $55.5K2020: $44.0K2021: $287.8K2022: $653.3K2023: $734.3K2024: $1.28M2025: $2.29M$2.29M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$2.29M+78.3%2024$1.28M+74.9%2023$734.3K+12.4%2022$653.3K+127.0%2021$287.8K+554.7%2020$44.0K-20.8%2019$55.5K-18.7%2018$68.3K+1320.7%2017$4.8K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share